In this free webinar, learn how integrated solutions — from vector design to cell-free in vitro transcription (IVT) template preparation —…
NEW YORK, July 30, 2025 /PRNewswire/ -- PAVmed Inc. (Nasdaq: PAVM) ("PAVmed" or the "Company"), a diversified commercial-stage medical technology company, operating…
Enrollment in Both Dose Cohorts of the MyPEAK™-1 Phase 1b/2 Clinical Trial of TN-201 for Hypertrophic Cardiomyopathy (HCM) Complete; Follow-up Data…
Initiation of additional trial sites and patient enrollment activities ongoing with multiple patients in screening LAWRENCEVILLE, N.J., July 30, 2025…
KUALA LUMPUR, Malaysia, July 30, 2025 (GLOBE NEWSWIRE) -- BioNexus Gene Lab Corp. (“BGLC”, Nasdaq: BGLC) and Fidelion Diagnostics Pte Ltd, a Singaporean company…
Leaders in pioneering cancer diagnostics and NGS target enrichment technologies join forces to accelerate access to advanced molecular diagnostics for…
The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated…
STUDIO CITY, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Today, the International Myeloma Foundation (IMF) announces with great sadness the…
LAWRENCEVILLE, N.J., July 29, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage company in late-stage development with its…
Mean signs and symptoms for participants in Stage 3 of the SAHARA trial remained statistically significantly better than study baseline…